awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38642455-0F2ED173-EC94-40D6-A481-791A8F9A0812
Q38642455-0F2ED173-EC94-40D6-A481-791A8F9A0812
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38642455-0F2ED173-EC94-40D6-A481-791A8F9A0812
Emerging molecular targets and therapy for cholangiocarcinoma.
P2860
Q38642455-0F2ED173-EC94-40D6-A481-791A8F9A0812
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38642455-0F2ED173-EC94-40D6-A481-791A8F9A0812
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7124bdb0e84b359a4250329504792daa39895807
P2860
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.